Kabra Drugs Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Kabra Drugs Ltd is ₹ 26.21 as of 06 May 15:30 . The P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Kabra Drugs Ltd changed from ₹ 2 crore on March 2022 to ₹ 26.27 crore on March 2025 . This represents a CAGR of 90.37% over 4 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Kabra Drugs Ltd for the Dec '25 is ₹ 30.6 crore as compare to the Sep '25 revenue of ₹ 19.94 crore. This represent the growth of 53.46% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 1.62 crore as compare to the Sep '25 revenue of ₹ 1.32 crore. This represent the growth of 22.73% The ebitda of Kabra Drugs Ltd for the Dec '25 is ₹ 2.62 crore as compare to the Sep '25 ebitda of ₹ 2.22 crore. This represent the growth of 18.02% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.05 crore. This represent the decline of -20% The net profit of Kabra Drugs Ltd changed from ₹ -0.55 crore to ₹ 2.57 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0.03 crore over 7 quarters. This represents a CAGR of 87.34% The Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kabra Drugs Ltd

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989.
The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
The commercial production commenced in 1991.
Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Kabra Drugs Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Kabra Drugs Ltd is 62 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 28 Cr

What are the key factors driving the stock performance of Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 6, 2026, the Kabra Drugs Ltd stock price is INR ₹26.21. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹24.7.

How do dividend payouts of Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Kabra Drugs Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.